Last $0.14 USD
Change Today -0.0056 / -3.89%
Volume 35.2K
CGNH On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/26/14 All times are local (Market data is delayed by at least 15 minutes).

cardiogenics holdings inc (CGNH) Snapshot

Open
$0.13
Previous Close
$0.14
Day High
$0.14
Day Low
$0.13
52 Week High
12/5/13 - $0.45
52 Week Low
07/8/14 - $0.10
Market Cap
5.1M
Average Volume 10 Days
19.6K
EPS TTM
--
Shares Outstanding
36.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CARDIOGENICS HOLDINGS INC (CGNH)

Related News

No related news articles were found.

cardiogenics holdings inc (CGNH) Related Businessweek News

No Related Businessweek News Found

cardiogenics holdings inc (CGNH) Details

CardioGenics Holdings Inc., a development stage company, engages in the development and commercialization of diagnostic test products for the immunoassay segment of the in vitro diagnostics testing market in the United States, Canada, and Europe. Its products include The QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests designed to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by medical laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings, Inc. in October 2009. CardioGenics Holdings Inc. was founded in 1997 and is headquartered in Mississauga, Canada.

7 Employees
Last Reported Date: 02/13/14
Founded in 1997

cardiogenics holdings inc (CGNH) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $147.5K
Chief Financial Officer
Total Annual Compensation: $35.2K
Secretary and Director
Total Annual Compensation: $25.1K
Compensation as of Fiscal Year 2013.

cardiogenics holdings inc (CGNH) Key Developments

CardioGenics Holdings Inc announced delayed annual 10-K filing

On 01/30/2014, CardioGenics Holdings Inc announced that they will be unable to file their next 10-K by the deadline required by the SEC.

CardioGenics Holdings Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013

CardioGenics Holdings Inc. reported earnings results for the third quarter and nine months ended July 31, 2013. For the third quarter, the company reported net loss attributable to the company of CAD 315,428, compared to a net loss attributable to the company of CAD 237,434, for the third quarter ended July 31, 2012. Operating loss for the third quarter ended July 31, 2013 was CAD 233,624, compared to an operating loss of CAD 234,340, for the third quarter ended July 31, 2012. Net loss attributable to the company for the nine months ended July 31, 2013 was CAD 757,094, or CAD 0.01 loss per share, compared to a net loss attributable to the company of CAD 944,106, or CAD 0.02 loss per share, for the nine months ended July 31, 2012. Operating loss for the nine months ended July 31, 2013 was CAD 648,153, compared to an operating loss of CAD 955,084, for the nine months ended July 31, 2012.

CardioGenics Holdings Inc announced delayed 10-Q filing

On 09/17/2013, CardioGenics Holdings Inc announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CGNH:US $0.14 USD -0.0056

CGNH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CGNH.
View Industry Companies
 

Industry Analysis

CGNH

Industry Average

Valuation CGNH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARDIOGENICS HOLDINGS INC, please visit www.cardiogenics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.